These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Sublingual buprenorphine (Temgesic) for the management of postoperative pain. A comparative study of intramuscular pethidine and buprenorphine]. Crawford ME, Carl P, Bøggild-Madsen NB, Ravlo O, Bach V, Larsen AI, Kruse L. Ugeskr Laeger; 1985 Jun 03; 147(23):1842-5. PubMed ID: 3895692 [No Abstract] [Full Text] [Related]
5. Activity and tolerability of buprenorphine after parenteral and sublingual administration. Rossano C, De Luca LF, Firetto V, Fossi F. Clin Ther; 1982 Jun 03; 5(1):61-8. PubMed ID: 7127370 [No Abstract] [Full Text] [Related]
6. Buprenorphine-supplemented anesthesia in abdominal surgery. Tashiro C, Aoki Y, Yoshiya I. Med J Osaka Univ; 1982 Sep 03; 33(1-2):35-40. PubMed ID: 7155049 [No Abstract] [Full Text] [Related]
9. Intra-muscular buprenorphine--clinical experience in its use for relieving pain due to malignant disease. Ostrowski MJ, Jackson AW. Br J Clin Pract; 1979 Oct 03; 33(10):286, 293. PubMed ID: 526414 [No Abstract] [Full Text] [Related]
10. [Premedication with buprenorphine hydrochloride. A clinical study]. Fritz KW, Zinck B, Lauchart W, Kirchner E. Intensivmed Prax; 1983 Oct 03; 6():47-51. PubMed ID: 6358046 [No Abstract] [Full Text] [Related]
12. Evaluation of the clearance of a sublingual buprenorphine spray in the beagle dog using gamma scintigraphy. McInnes F, Clear N, James G, Stevens HN, Vivanco U, Humphrey M. Pharm Res; 2008 Apr 03; 25(4):869-74. PubMed ID: 17763831 [Abstract] [Full Text] [Related]
13. High dose buprenorphine for postoperative analgesia. Papworth DP. Anaesthesia; 1983 Feb 03; 38(2):163. PubMed ID: 6829887 [No Abstract] [Full Text] [Related]
15. Pharmacokinetics and pharmacodynamics of multiple sublingual buprenorphine tablets in dose-escalation trials. Ciraulo DA, Hitzemann RJ, Somoza E, Knapp CM, Rotrosen J, Sarid-Segal O, Ciraulo AM, Greenblatt DJ, Chiang CN. J Clin Pharmacol; 2006 Feb 11; 46(2):179-92. PubMed ID: 16432270 [Abstract] [Full Text] [Related]
16. Uptake of etorphine and dihydromorphine after sublingual and intramuscular administration. Dobbs HE, Blane GF, Boura AL. Eur J Pharmacol; 1969 Sep 11; 7(3):328-32. PubMed ID: 5351989 [No Abstract] [Full Text] [Related]
17. Groin tissue necrosis requiring skin graft following parenteral abuse of buprenorphine tablets. Feeney GF, Fairweather P. Drug Alcohol Rev; 2003 Sep 11; 22(3):359-61. PubMed ID: 15385230 [Abstract] [Full Text] [Related]
18. Relative bioavailability of different buprenorphine formulations under chronic dosing conditions. Strain EC, Moody DE, Stoller KB, Walsh SL, Bigelow GE. Drug Alcohol Depend; 2004 Apr 09; 74(1):37-43. PubMed ID: 15072805 [Abstract] [Full Text] [Related]
19. Transdermal buprenorphine in the treatment of chronic pain: results of a phase III, multicenter, randomized, double-blind, placebo-controlled study. Sorge J, Sittl R. Clin Ther; 2004 Nov 09; 26(11):1808-20. PubMed ID: 15639693 [Abstract] [Full Text] [Related]
20. The systemic bioavailability of buprenorphine by various routes of administration. Brewster D, Humphrey MJ, Mcleavy MA. J Pharm Pharmacol; 1981 Aug 09; 33(8):500-6. PubMed ID: 6115924 [Abstract] [Full Text] [Related] Page: [Next] [New Search]